The Committee for Medicinal Products for Human Use (CHMP) decided that TachoSil’ s benefits are greater than its risks for supportive treatment in surgery for the improvement of haemostasis, to promote tissue sealing and for suture support in vascular surgery where standard techniques are insufficient.